She adds another explanation for why some individuals might seem to observe this association: Weight gain is also linked to the perimenopausal and post-menopausal state, and a GLP-1 is a reasonable treatment for this for those who qualify. What this means is that for some women, the weight loss effects of a GLP-1 and the symptoms of low estrogen may occur at the same time, making it difficult to tell whether the changes are due to the medication, hormonal shifts, or both
Advise patients to seek medical advice promptly during periods of stress (e.g., fever, trauma, infection, surgery) as medication requirements may change
Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity
Her ears rang occasionally